A dual-multivalent aptamer-DNA nanocarriers for enhancing antitumor effects of photodynamic-chemotherapy combined therapy
Colloids and Surfaces B: Biointerfaces · 2026
DOI: 10.1016/j.colsurfb.2025.115201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026. Verfasst von Tianxin Weng und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Photochemotherapy, Doxorubicin, Drug Carriers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Shandong Province Natural Science Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The clinical application of photodynamic therapy (PDT) is limited by the poor targeting of photosensitizers, tumor hypoxia and low single efficacy. Herein, a multifunctional DNA nanocarriers (AMH-Ncas) utilizing rolling circle amplification (RCA) technology was developed for precise targeted delivery of PDT-chemotherapy combination drugs and enhanced PDT efficacy. AMH-Ncas had an RCA scaffold with repeats units, which can self-assemble with the functional complementary chains of AS1411 aptamers, MUC1 aptamers and hypoxia inducible factor 1α (HIF-1α) antisense DNA. The thermodynamic data of the binding of photosensitizer new methylene blue N (NMBN) and chemotherapeutic drug doxorubicin (DOX) to AMH-Ncas indicated that AMH-Ncas had higher drug loading capacity and the first loading of NMBN was more favorable. Deoxyribonuclease I accelerated the release of drugs loaded by AMH-Ncas, and NMBN with weaker binding ability released the fastest. The dual-multivalent aptamer of AMH-Ncas enhanced its targeting ability to MCF-7 cells. The HIF-1α antisense DNA alleviated the hypoxia of MCF-7 cells by inhibiting the expression of HIF-1α, which increased the PDT efficiency by 62.9 %. AMH-Ncas + NMBN + DOX system exhibited excellent synergistic anti-tumor effects. This study provides a theoretical basis for the co-delivery of combined drugs by DNA nanocarriers to achieve enhanced PDT-chemotherapy synergistic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China.
- College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China. Electronic address: zhangzq@upc.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- Shandong Province Natural Science Foundation
Zitieren
APA
Weng, T., Zhang, G., Ding, K., Huo, X., Wang, X., Zhou, T., Wang, F., & Zhang, Z. (2026). A dual-multivalent aptamer-DNA nanocarriers for enhancing antitumor effects of photodynamic-chemotherapy combined therapy. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2025.115201
Vancouver
Weng T, Zhang G, Ding K, Huo X, Wang X, Zhou T, et al. A dual-multivalent aptamer-DNA nanocarriers for enhancing antitumor effects of photodynamic-chemotherapy combined therapy. Colloids and Surfaces B: Biointerfaces. 2026. doi:10.1016/j.colsurfb.2025.115201
BibTeX
@article{Weng2026,
author = {Weng, Tianxin and Zhang, Guodong and Ding, Kexin and Huo, Xiaobing and Wang, Xiufeng and Zhou, Ting and Wang, Fang and Zhang, Zhiqing},
title = {A dual-multivalent aptamer-DNA nanocarriers for enhancing antitumor effects of photodynamic-chemotherapy combined therapy},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2026},
doi = {10.1016/j.colsurfb.2025.115201}
}
EUVIMED